about
The impact of anti-inflammatory cytokines on the pancreatic β-cellEnterovirus and type 1 diabetes: What is the matter?Maternal microchimerism: friend or foe in type 1 diabetes?Rotavirus infection induces transient pancreatic involution and hyperglycemia in weanling mice.Role of viruses and other microbes in the pathogenesis of type 1 diabetes.Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes.Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetes.Novel aspects of pathogenesis and regeneration mechanisms in COPDDoes the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the diseaseReduction of circulating neutrophils precedes and accompanies type 1 diabetesThe role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset.Helminth infection and type 1 diabetes.Altered immune regulation in type 1 diabetes.Detection and localization of viral infection in the pancreas of patients with type 1 diabetes using short fluorescently-labelled oligonucleotide probes.Virus infections as potential targets of preventive treatments for type 1 diabetesAdvances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.The role of interferon induced with helicase C domain 1 (IFIH1) in the development of type 1 diabetes mellitus.Toll-like receptor 3 (TLR3) and the development of type 1 diabetes mellitus.Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk.Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes?An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine kinase 2 (TYK2) Promoter Variant in the Japanese.Manipulating Glucose Metabolism during Different Stages of Viral Pathogenesis Can Have either Detrimental or Beneficial Effects.Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.A Mathematical Model of T1D Acceleration and Delay by Viral Infection.Fibroblasts from type 1 diabetics exhibit enhanced Ca(2+) mobilization after TNF or fat exposure.Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset.Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences.Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells.Murine Gammaherpesvirus 68: A Small Animal Model for Gammaherpesvirus-Associated Diseases.The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice.Mining the Virome for Insights into Type 1 Diabetes.Antibody cross-reactivity and the viral aetiology of type 1 diabetes.
P2860
Q26822824-7E3E3A88-92E1-4A11-B873-284797BEC553Q26830009-F9E06DC1-4A41-4276-895E-5C9939CCD88FQ26851151-D981F8EE-4F39-43AB-8922-17B68C94B9C6Q34122552-11F16AC3-5266-4AE1-B796-C0D9D4A05BECQ35115373-B7E6E3B2-FEC2-4147-811A-72438A0D55CDQ35152520-02AD572B-F660-4CF1-A85E-A1761396ED80Q35407467-CE9D07E1-57B5-4760-9CD4-E88809C0DCB9Q35665638-01BE4214-35C4-4FC5-A423-459EC39ADE64Q36393941-FDAF2873-9A95-4535-B457-CE955D449987Q36867514-1DC2FEDC-125B-423E-95AB-3042D7DADE27Q36995532-7BC3BB59-A299-4181-B230-F9D99B245888Q37047277-339B2A42-8DAA-43A1-BEDE-9C30DD2141B4Q37088203-D25FE4A7-83E9-4F3E-ABD1-26C0FBE62EC2Q37148578-17099555-1A71-4F1A-97B8-5DF61CF094D8Q37706460-BABBDD0B-E4DB-4C31-B238-C81218485B30Q38117281-247DD712-8228-4592-BFE0-293B3529D4A3Q38135862-1C11EC1F-0EC9-45B4-BEEC-84C63C49ACB0Q38176747-283ECC20-9B12-438E-9917-47E8CE8F3D3DQ38450410-42A4796D-F6CE-441E-9F31-6D856A739423Q38734595-EFCD290B-689D-417D-BCC1-50F856A0CFF5Q39012899-B499C3C0-5FBB-4990-A4AC-33D976B0BBCAQ40054894-B7F4F60C-EE34-4191-BAE9-CCDAE8276B40Q40076459-CE59C4BB-FE2F-4A88-B7F5-1A7F5D40DD5BQ40097679-A350AF7B-4D67-4D9C-A6DE-CF9E9E066FA5Q40127622-B7C8EF0D-FCF9-43F4-9B15-75C762FBE4D9Q40734921-98C39370-5CAB-4E48-8E5B-4212CD6A8570Q41888774-C708321F-63EF-4E16-BAAE-E4E413CD7DDFQ41919675-D6312015-18EC-4EE7-8FA3-46BEEE33DB32Q42200757-28DFB6B1-571F-44FE-90B3-EC771025126FQ47128638-C5E87BA1-E01B-4E33-B011-1D74123733CBQ47606264-8E3D82E2-C116-422F-AE85-593D40032892Q47913426-214219CE-256C-47EE-ACD4-D0441B0843DEQ54237931-38A82F7D-8950-4620-8AF9-8E35C8665790Q54451382-6B21C791-52B3-424C-916C-71BC3FA19FB5
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Virus infections in type 1 diabetes
@ast
Virus infections in type 1 diabetes
@en
Virus infections in type 1 diabetes
@nl
type
label
Virus infections in type 1 diabetes
@ast
Virus infections in type 1 diabetes
@en
Virus infections in type 1 diabetes
@nl
prefLabel
Virus infections in type 1 diabetes
@ast
Virus infections in type 1 diabetes
@en
Virus infections in type 1 diabetes
@nl
P2093
P2860
P3181
P1476
Virus infections in type 1 diabetes
@en
P2093
K. T. Coppieters
M. von Herrath
T. Boettler
P2860
P304
P3181
P356
10.1101/CSHPERSPECT.A007682
P407
P577
2012-01-01T00:00:00Z